Orthofix Medical Inc. (OFIX) stock

OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3051% below fair value

$6.94−0.24 (-3.34%)

Close on Nov 12, 2026Market cap $282.68MP/E –Yield –

Orthofix Medical EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Orthofix Medical's EV/EBITDA was 30.0× on Nov 11, 2026, against 17.6× a year earlier. Over the last 5 years it ranged from 11.6× to 104.6×, with a median of 25.3×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	30.0×	+9.1
2023	Apr 28, 2023	20.9×	+0.3
2022	Dec 30, 2022	20.6×	+5.4
2021	Dec 31, 2021	15.1×	−17.9
2020	Dec 31, 2020	33.0×	−31.1
2019	Dec 31, 2019	64.2×	+47.1
2018	Dec 31, 2018	17.0×	−1.4
2017	Dec 29, 2017	18.4×	−10.4
2016	Dec 30, 2016	28.8×	−87.3
2015	Dec 31, 2015	116.1×	+96.8
2014	Dec 31, 2014	19.3×	+10.3
2013	Dec 31, 2013	9.0×	−0.0
2012	Dec 31, 2012	9.0×	−32.1
2011	Dec 30, 2011	41.2×	+35.5
2010	Dec 31, 2010	5.6×	–

Where these numbers come from

Parsed from the XBRL in Orthofix Medical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing